TGFB1 and neoplasm: From a translational perspective, the relevance of this pathway is underscored by preclinical and early clinical studies in solid tumours demonstrating that TGF‐β blockade restores anti‐tumour immunity,57, 58, 59 suggesting potential applicability in HBV+ DLBCL.